Our Clinical Approach to Cases with Silicone Oil Droplets in Vitreus Following Intravitreal Injection
Pur po se: To demonstrate that post-injection intravitreal silicone oil droplets can be seen as a complication in the follow-up of patients who had undergone intravitreal injection treatment and to discuss our clinical approach to these patients. Ma te ri al and Met hod: Out of 6 patients who had...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Yayinevi
2012-12-01
|
| Series: | Türk Oftalmoloji Dergisi |
| Subjects: | |
| Online Access: | http://www.oftalmoloji.org/article_2210/Our-Clinical-Approach-To-Cases-With-Silicone-Oil-Droplets-In-Vitreus-Following-Intravitreal-Injection |
| Summary: | Pur po se: To demonstrate that post-injection intravitreal silicone oil droplets can be seen as a complication in the follow-up of
patients who had undergone intravitreal injection treatment and to discuss our clinical approach to these patients.
Ma te ri al and Met hod: Out of 6 patients who had undergone intravitreal injection treatment in T. C. Istanbul Bilim University
Ophthalmology Clinic between December 2010 and February 2011, four presented with complaints of floaters and 2 patients applied for followup
after intravitreal injection.
Re sults: On ophthalmological examination, free silicone oil droplets in the vitreous cavity were observed at fundoscopy. In 0.04% of
patients who had undergone bevacizumab injections, intravitreal silicone oil droplets were seen, whereas no oil droplets were seen in
patients who had undergone ranibizumab injections. Before silicone oil droplets were seen in the vitreous, the mean number of
injections was 4.8 (3-8) and the mean number of the total injections that the patients have undergone was 6.8 (3-9). Two of the 6
patients were asymptomatic and 4 of them were symptomatic. The silicone oil droplets in the vitreous which were on the optical axis
were extracted with pars plana vitrectomy method in two symptomatic patients. Pathological examination of the vitreous extracts
confirmed that the observed droplets were silicone oil.
Dis cus si on: In our study, it was determined that the injector equipment which is used in bevacizumab injections can bring along
the complication of silicone oil droplets in the vitreous cavity and this situation can be prevented with equipment changing. (Turk J
Ophthalmol 2012; 42: 454-7) |
|---|---|
| ISSN: | 1300-0659 2147-2661 |